Cargando…
Molecular Recognition of FDA-Approved Small Molecule Protein Kinase Drugs in Protein Kinases
Protein kinases are key enzymes that catalyze the covalent phosphorylation of substrates via the transfer of the γ-phosphate of ATP, playing a crucial role in cellular proliferation, differentiation, and various cell regulatory processes. Due to their pivotal cellular role, the aberrant function of...
Autores principales: | Zhu, Yan, Hu, Xiche |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611543/ https://www.ncbi.nlm.nih.gov/pubmed/36296718 http://dx.doi.org/10.3390/molecules27207124 |
Ejemplares similares
-
Aromatic Rings as Molecular Determinants for the Molecular Recognition of Protein Kinase Inhibitors
por: Zhu, Yan, et al.
Publicado: (2021) -
Anti-Cancer Drugs Targeting Protein Kinases Approved by FDA in 2020
por: Cicenas, Jonas, et al.
Publicado: (2021) -
Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus Kinases
por: Mayence, Annie, et al.
Publicado: (2019) -
A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors
por: Jin, Ying, et al.
Publicado: (2020) -
Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases
por: Rodrigues, Daniel A., et al.
Publicado: (2019)